Historic Marijuana Reclassification: Changes & Implications

April 16, 2026
Live Webinar
DateApr 16, 2026Duration60 minutes
12:00 PM PDT01:00 PM MDT
02:00 PM CDT03:00 PM EDT
  • Unlimited connections for your agency
  • Available on desktop, mobile & tablet
  • Take-away toolkit
  • Presenter’s contact info for questions
On-Demand Webinar
  • Unlimited & shareable access starting
    two business days after live stream
  • Available on desktop, mobile & tablet devices 24/7
  • Take-away toolkit
  • Ability to download webinar video
  • Presenter's contact info for questions

See Registration Options

From Schedule 1 to Schedule 3: What does marijuana rescheduling mean for your organization?

An executive order reclassifying medical marijuana was issued at the end of 2025, marking a historic shift with far-reaching implications for healthcare. Join us as we explore the impact this may have on organizational marijuana policies, employee use, patient care, drug testing, accommodations, HIPAA considerations, and key HR and business decisions so your agency can respond proactively and compliantly.

KEY WEBINAR TAKEAWAYS
  • How historic marijuana rescheduling does — and does not — impact hospice and home care company employees, patients, and business processes
  • Current legal status of medical marijuana in light of historic rescheduling
  • How reclassification affects your marijuana policy and procedures

BONUS MATERIALS

  • Whitepaper: Marijuana Policy & Best Practices: Handling Employee Medical & Recreational Use
  • Marijuana Rules: Guidelines for Creating Effective Cannabis Policy & Procedures

WEBINAR DETAILS

At year-end 2025, the long-awaited rescheduling of marijuana took a big step forward when President Trump signed an executive order reclassifying medical marijuana from a Schedule 1 drug (on par with heroin) to a Schedule 3 drug (comparable to Tylenol® with Codeine No. 3). Once enshrined as law, the historic rescheduling of medical marijuana will favorably impact the cannabis industry — and potentially could impact hospices and home care companies. This webinar will discuss what marijuana reclassification does (and does not) mean for the healthcare industry. Learn what this rescheduling means (or does not mean) for your organization’s marijuana policy, people, patients, testing program, terminations, accommodations, and other HR, HIPAA, and business issues.

THIS WEBINAR WILL BENEFIT THE FOLLOWING AGENCIES:

  • Hospice
  • Home Care
  • Home Health
  • Palliative Care

WHO SHOULD ATTEND?

  • Compliance
  • HR
  • Training
  • Legal
  • Managers and executives
  • Anyone responsible for workplace policy and compliance

TAKE-AWAY TOOLKIT

  • Employee training log
  • Interactive quiz
  • PDF of slides and speaker’s contact info for follow-up questions
  • Attendance certificate provided to self-report CE credits

NOTE: All materials are subject to copyright. Transmission, retransmission, or republishing of any webinar to other institutions or those not employed by your institution is prohibited. Print materials may be copied for eligible participants only.

Presented By

Nancy Flynn,Nancy Flynn
The ePolicy Institute™, Business Writing Institute™ & Marijuana Policy Institute™
© 2026 FINANCIAL EDUCATION & DEVELOPMENT, INC